Sight Sciences, Inc.
SGHT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $19,906 | $19,564 | $17,508 | $19,074 |
| % Growth | 1.7% | 11.7% | -8.2% | – |
| Cost of Goods Sold | $2,709 | $2,977 | $2,414 | $2,513 |
| Gross Profit | $17,197 | $16,587 | $15,094 | $16,561 |
| % Margin | 86.4% | 84.8% | 86.2% | 86.8% |
| R&D Expenses | $3,352 | $4,387 | $4,430 | $4,293 |
| G&A Expenses | $0 | $0 | $0 | $22,797 |
| SG&A Expenses | $21,750 | $23,867 | $24,523 | $24,197 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1,400 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $25,102 | $28,254 | $28,953 | $28,490 |
| Operating Income | -$7,905 | -$11,667 | -$13,859 | -$11,929 |
| % Margin | -39.7% | -59.6% | -79.2% | -62.5% |
| Other Income/Exp. Net | -$343 | -$234 | -$254 | $121 |
| Pre-Tax Income | -$8,248 | -$11,901 | -$14,113 | -$11,808 |
| Tax Expense | -$79 | $40 | $41 | $38 |
| Net Income | -$8,169 | -$11,941 | -$14,154 | -$11,846 |
| % Margin | -41% | -61% | -80.8% | -62.1% |
| EPS | -0.16 | -0.23 | -0.28 | -0.23 |
| % Growth | 30.4% | 17.9% | -21.7% | – |
| EPS Diluted | -0.16 | -0.23 | -0.28 | -0.23 |
| Weighted Avg Shares Out | 52,378 | 51,822 | 51,291 | 50,797 |
| Weighted Avg Shares Out Dil | 52,378 | 51,822 | 51,291 | 50,797 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1,026 | $0 | $0 |
| Interest Expense | $1,306 | $1,284 | $1,263 | $1,161 |
| Depreciation & Amortization | $105 | $125 | $149 | $176 |
| EBITDA | -$6,837 | -$10,492 | -$12,701 | -$10,471 |
| % Margin | -34.3% | -53.6% | -72.5% | -54.9% |